Equillium, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:EQ) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Cash from operating activities -8.17 M-3.01 M-8.43 M-3.13 M-4.3 M -18.88 M Cash from investing activities 4.5 M00-32 K-3 000 -35 K Cash from financing activities 91 K-16 K30.07 M283 K35.35 M 65.68 M Free cash flow -8.17 M-3.01 M-8.43 M-3.13 M-4.3 M -18.88 M

News

Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory Disease Transcript

Forte Biosciences: 2026 Is Major Inflection Point For FB102 (NASDAQ:FBRX)

Equillium (EQ) SVP Zedelmayer sells $300k in shares

Equillium secures $35M financing from RA Capital Management

Roth/MKM initiates Equillium stock with buy on ulcerative colitis drug

Equillium SVP Zedelmayer sells $328k in shares

Stifel initiates Equillium stock with buy rating on IBD potential

Equillium principal accounting officer Tom Penny sells $8427 in stock

Equillium SVP Zedelmayer sells $7.7k in stock

The Zacks Analyst Blog Highlights MS, VOO, SPY, IVV, SPYM, RSP, EQ and EQWL

Equillium, Inc. (EQ) Discusses Aryl Hydrocarbon Receptor as a Drug Target and EQ504 Program in Immune-Mediated Diseases - Slideshow (NASDAQ:EQ) 2025-11-09

Equillium announces leadership changes as it shifts focus to EQ504